Data / Drug companies / Guardian Drug Company
Guardian Drug Company: 47 products in the FDA NDC directory, labeler code 53041
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guardian Drug Company (labeler code 53041) lists 47 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 39 over the counter drugs, 8 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 2, 2026.
The request: Watch Guardian Drug Company (FDA labeler code 53041): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53041
- Products in commercial distribution
- 47
- Packages
- 71
- Finished drugs by generic name
- 18
- Prescription products
- 8
- Over the counter products
- 39
- Flagged as original packager
- 46 of 46 products that carry the flag
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- February 2, 2002
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 26 | 55.3% |
| Generic drugs (ANDA) | 21 | 44.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 39 | 83% |
| Prescription drugs | 8 | 17% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Calcium carbonate | 8 | 101 |
| Ibuprofen | 7 | 190 |
| Bismuth subsalicylate | 5 | 80 |
| Guaifenesin | 4 | 123 |
| Potassium chloride | 3 | 84 |
| Simethicone | 2 | 86 |
| Omeprazole, sodium bicarbonate | 2 | 9 |
| Diatrizoate meglumine and diatrizoate sodium | 2 | 4 |
| Dextromethorphan hbr, guaifenesin, phenylephrine hcl | 2 | 28 |
| Loperamide hydrochloride, simethicone | 1 | 20 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Calcium polycarbophil | 1 | 33 |
| Sennosides | 1 | 65 |
| Acteaminophen, guaifenesin, phenylephrine hcl | 1 | 1 |
| Diphenhydramine hcl | 1 | 99 |
| Esomeprazole magnesium | 1 | 77 |
| Aluminum hydroxide, magnesium hydroxide, simethicone | 1 | 20 |
| Levetiracetam | 1 | 87 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 12 | 25.5% |
| Liquid | 12 | 25.5% |
| Suspension/ drops | 7 | 14.9% |
| Solution | 5 | 10.6% |
| Tablet, extended release | 4 | 8.5% |
| Tablet | 2 | 4.3% |
| Capsule | 2 | 4.3% |
| Tablet, film coated | 1 | 2.1% |
| Capsule, delayed release | 1 | 2.1% |
| Powder, for solution | 1 | 2.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Childrens Ibuprofen Bubblegum Dye Free | 53041-811 | Suspension/ drops | Generic drugs (ANDA) | November 2, 2026 |
| Antacid | 53041-509 | Liquid | Over the counter monograph drugs | August 26, 2026 |
| Maximum Strength Antacid Mint | 53041-100 | Tablet, chewable | Over the counter monograph drugs | July 13, 2026 |
| Levetiracetam | 53041-660 | Solution | Generic drugs (ANDA) | December 2, 2025 |
| Potassium Chloride | 53041-420 | Powder, for solution | Generic drugs (ANDA) | July 22, 2025 |
| Ultra Strength Stomach Relief | 53041-529 | Liquid | Over the counter monograph drugs | February 10, 2025 |
| Maximum Strength Stomach Relief | 53041-528 | Liquid | Over the counter monograph drugs | February 10, 2025 |
| Ultra Strength Antacid Assorted Berries | 53041-161 | Tablet, chewable | Over the counter monograph drugs | February 6, 2025 |
| Gas relief | 53041-103 | Tablet, chewable | Over the counter monograph drugs | February 6, 2025 |
| GDC Extra strength Alkums Antacid 127AF | 53041-102 | Tablet, chewable | Over the counter monograph drugs | August 13, 2024 |
| Guardian Extra Strength Smooth Alkum Antacid 173bf | 53041-717 | Tablet, chewable | Over the counter monograph drugs | May 1, 2024 |
| Guardian Ultra Strength Antacid Assorted Fruit | 53041-171 | Tablet, chewable | Over the counter monograph drugs | April 29, 2024 |
| Nighttime Sleep-Aid | 53041-633 | Liquid | Over the counter monograph drugs | January 11, 2024 |
| Guardian Extra Strength Assorted Berry Antacid Extra strength Assorted Berry Antacid | 53041-184 | Tablet, chewable | Over the counter monograph drugs | December 5, 2023 |
| Guardian Pink-Bismuth Cherry | 53041-022 | Tablet, chewable | Over the counter monograph drugs | December 4, 2023 |
| Esomeprazole Magnesium | 53041-666 | Capsule, delayed release | Generic drugs (ANDA) | March 24, 2023 |
| Guardian Extra Strength Antacid | 53041-130 | Tablet, chewable | Over the counter monograph drugs | May 2, 2022 |
| Childrens Ibuprofen grape | 53041-639 | Suspension/ drops | Generic drugs (ANDA) | October 13, 2021 |
| Childrens Ibuprofen blue raspberry | 53041-638 | Suspension/ drops | Generic drugs (ANDA) | October 13, 2021 |
| Childrens Ibuprofen fruit | 53041-632 | Suspension/ drops | Generic drugs (ANDA) | October 13, 2021 |
| Childrens Ibuprofen bubblegum | 53041-572 | Suspension/ drops | Generic drugs (ANDA) | October 13, 2021 |
| Guardian Pink Bismuth | 53041-021 | Tablet, chewable | Over the counter monograph drugs | October 8, 2021 |
| Guardian Regular Strength Alkums | 53041-098 | Tablet, chewable | Over the counter monograph drugs | October 5, 2021 |
| Potassium Chloride | 53041-681 | Solution | Generic drugs (ANDA) | July 9, 2021 |
| Potassium Chloride | 53041-680 | Solution | Generic drugs (ANDA) | July 9, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.